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Abstract
Background: The etiology of ulcerative colitis (UC) is to be understood. The basic pathological
feature of UC is intestinal chronic inflammation. Superantigen, such as Staphylococcus enterotoxin
B (SEB), is reported to compromise intestinal barrier function by increasing epithelial permeability
and initiate inflammation in the intestinal mucosa. Inasmuch as anatomic position of the sinus,
chronic sinusitis-derived SEB may follow the secretion and to be swallowed down to the
gastrointestinal tract and induce lesions to the intestinal mucosa.
Methods: Sinus wash fluid (SWF, containing SEB) was collected from a group of patients with both
chronic sinusitis (CS) and UC. A group of mice were sensitized to ovalbumin (OVA) in the presence
of SWF. The sensitized mice were challenged with the specific antigen OVA. The inflammatory
status of the colonic tissue was determined with histology, serology and electron microscopy.
Using horseradish peroxidase (HRP) as a tracer, another group of mice was stimulated with SWF
for 2 hours. The HRP activity was detected in the colonic tissue with enzymatic approaches and
electron microscopy.
Results: Epithelial hyperpermeability in colonic epithelium was induced by stimulating with SWF.
The HRP activity in the colonic mucosa was almost 11 times more in the SWF treated group (3.2
± 0.6 µg/g tissue) than the control group (0.3 ± 0.1 µg/g tissue). Mice were sensitized using a
mixture of SWF and OVA (serum OVA-specific IgE was detected with a highest titer as 1:64).
Challenge with OVA induced extensive inflammation in the colonic mucosa by showing (1) marked
degranulation in mast cells (MC, 46.3 ± 4.5%) and eosinophils (Eo, 55.7 ± 4.2%); (2) inflammatory
cell infiltration (MC = 145.2 ± 11.4; Eo = 215.8 ± 12.5; mononuclear cell = 258.4 ± 15.3/mm2 tissue);
(3) increased MPO activity (12.9 ± 3.2 U/g tissue) and inflammatory scores (1.8 ± 0.3); (4) mucosal
surface ulcers; (5) edema in the lamina propria; (6) bacterial translocation and abscess formation in
the subepithelial region.
Conclusion:  Introducing Sinusitis-derived SEB-containing SWF to the gastrointestinal tract
compromised colonic mucosal barrier function increasing epithelial permeability to luminal
macromolecular protein in mice. The SWF facilitated colonic mucosal sensitization to luminal
antigen. Multiple challenging the sensitized colonic mucosa with specific antigen OVA induced
inflammation, induced a condition similar to human ulcerative colitis.
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Background
Ulcerative colitis (UC) is a disease characterized by
inflammation and ulcers in the mucosa of the large intes-
tine with unknown etiology. The inflammation usually
occurs in the rectum and lower part of the colon, but it
may affect the entire colon. The inflammation speeds up
colonic motility and causes diarrhea. Ulcers form in
places where the inflammation has killed the cells lining
the colon; the ulcers bleed and produce pus. Theories
about what causes ulcerative colitis abound, but none
have been proven. The most popular theory is that the
body's immune system reacts to a virus or a bacterium
causing ongoing inflammation in the intestinal mucosa;
others include genetic predisposition, autoimmune disor-
ders and impaired immune regulation [1-3].
over the past 15 years, more than 2000 patients with
chronic sinusitis (CS) including some patients with both
CS and UC visited our clinic and were treated with differ-
ent remedies, including medical treatment and functional
sinus endoscopic surgery (FESS). Apart from improve-
ment of chronic sinusitis, those patients with both CS and
UC showed great improvement of UC as well (data not
shown) that couldn't be explained with the specific treat-
ment alone. Therefore, we postulated that there might be
an association between CS and UC in these patients.
Microbial infection is the most common cause of CS. The
microbial products, such as lipopolysaccharide (LPS), sta-
phylococcus aureus enterotoxin B (SEB) [4,5] can be dis-
charged into the nasal cavity through the natural ostia
going backward to the pharynx, and then be swallowed,
entering the gastrointestinal tract to affect mucosal physi-
ological functions [6,7].
Staphylococcus enterotoxin B is an extracellular toxin pro-
duced by certain strains of Staphylococcus aureus (S. aureus)
[8]. Many cases of food poisoning worldwide involve S.
aureus enterotoxins [9]. In addition, enterotoxins can be
found in cases of toxic shock syndrome [10] and have
been implicated in the autoimmune disease rheumatoid
arthritis [11]. SEB is synthesized as a precursor protein of
266 amino acids. This precursor is then activated during
excretion by cleavage of the N-terminal portion of the
molecule. The active enterotoxin B is a single 239 amino
acid chain of molecular weight 28,000 daltons and isoe-
lectric point of 8.6 [12]. SEB is a superantigen and pos-
sesses powerful immune regulatory capability that results
in increased T cell activation and proliferation. SEB-
treated Balb/c mice display a dose-dependent colonic
inflammation [13]. SEB can also induce colonic epithelial
barrier dysfunction [14] that may promote uptake of
exogenous antigens, microbial products and other nox-
ious substances into the intestinal tissue to contact
immune cells and initiate inappropriate immune
reactions.
The nasal cavity and sinus are primary sites of coloniza-
tion by S. aureus, and a quantity of SEB was detected in the
nasal cavity of the patients with allergic rhinitis [15,16].
Based on clinical observations, we hypothesized that
sinusitis-derived SEB plays a certain role in the pathogen-
esis of chronic inflammation in the intestinal mucosa via
impairing the epithelial barrier function and inducing
inappropriate immune reactions. In this study, we aimed
to investigate if (1) sinusitis-derived SEB increases intesti-
nal permeability in the mice; (2) the presence of sinusitis-
derived SEB facilitates intestinal sensitization to luminal
antigen; (3) oral challenge with specific antigen induces
intestinal allergic inflammation in the sensitized animals.
Accordingly, we developed a murine model of ulcerative
colitis with oral allergen in the presence of SEB-containing
SWF. The animal model showed intestinal inflammation
associated with intestinal mucosal eosinophilia, mastocy-
tosis, acute diarrhea, bacterial translocation and micro-
ulcer formation on the surface of the colonic mucosa.
Methods
Sinus-wash fluids collected from the patients with CS and 
UC
Sinus-wash fluids (SWF) were collected from 32 patients
with both CS and UC (18 male and 14 female; aged from
26 to 58, with an average of 35.82). We diagnosed CS in
the patients as an inflammation of the sinus mucosa with
a persistent mucoid or mucopurulent nasal discharge for
longer than 3 months that resisted antimicrobial therapy
and antral irrigation. Diagnosis was made on the basis of
clinical history, rhinoscopic findings, and computed tom-
ographic scan of paranasal sinuses. CS was confirmed by
computed tomographic examination that showed diffuse
mucosal thickening in the ethmoid or/and maxillary
sinuses bilaterally with scores higher than 12 by the Lund-
Mackay staging system [17]. Twenty-five healthy medical
students were enrolled in this study, their nasal wash flu-
ids were used as controls.
The diagnosis of UC was based on clinical history, colon-
oscopy and histology. The history included persistent
bloody diarrhea, rectal urgency, or tenesmus. Examina-
tions and sigmoidoscopy and biopsy were performed to
confirm the presence of colitis and to exclude the presence
of infectious etiologies.
Every patient underwent maxillary sinus puncturing and
washing. The SWF was collected prior to other procedures.
Five ml saline was injected into the sinus cavities and re-
collected and stored at -70°C for further use. SEB content
in SWF was evaluated with ELISA (All the reagents used in
this study were purchased from Sigma unless otherwise
mentioned). None of the subjects had recent upper respi-
ratory acute infections. This study was approved by theBMC Gastroenterology 2005, 5:6 http://www.biomedcentral.com/1471-230X/5/6
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Ethical Committee of the First Hospital of Shanxi Medical
University.
Animals
For the purpose of verifying our hypothesis of an associa-
tion between sinus pathology and colitis, an animal
model of ulcerative colitis was developed. Mice were sen-
sitized to a model food antigen, ovalbumin (OVA) with or
without the presence of SEB-containing SWF. Animal
experiments were approved by Animal Use and Care
Committee at Shanxi Medical University. Male Balb/c
mice (10 week old) were purchased from Beijing Animal
Research Institute and maintained in the animal center at
Shanxi Medical University. All mice were housed accord-
ing to guidelines of the animal center. Water was available
continuously through automatic ports, and a commercial
mouse diet was provided ad libitum.
Effect of SEB containing SWF on colonic epithelial 
permeability in the mice
A group of mice was introduced 0.2 ml SWF (containing
SEB 50 µg and 10 mg horseradish peroxidase, HRP. SWF
was concentrated with the method of ammonium sulfate
precipitation for higher content of SEB) via intragastric
gavage under a light anesthetization. Mice were killed by
cervical dislocation 2 hours later (based on preliminary
results; data not shown). Control groups were designed
as: a naïve control group, treated with HRP 10 mg in 0.2
ml PBS via intragastric gavage; an inactivated-SWF control
group, the SWF was pretreated with anti-SEB (100 µg in
0.2 ml) for 30 min, then introduced to the mice in gavage
with HRP. Colon was removed; a piece of colon (3 cm)
was opened; the contents were collected and dissolved in
1 ml PBS for HRP assay; the colon tissue was snap frozen
and stored at -70°C for HRP assay; another piece of colon
(2 × 2 × 4 mm) was fixed with 2.5% glutaraldehyde for 2
hours; then rinsed in sodium cacodylate buffer, incubated
in 3,3'-diaminobenzidine tetrahydrochlorine and H2O2
(pH 7.6) for 30 min, and postfixed with 2% osmium
tetroxide for 60 minutes, followed by staining en bloc
with 4% uranyl acetate for 30 minutes. Tissue samples
were dehydrated through a graded series of ethanol,
cleared in propylene oxide, and embedded in Epoxy
embedding medium. Thin sections were prepared and
stained with 4% uranyl acetate for 5 min and subse-
quently with 2.5% lead citrate for 2 min and examined at
80 kV with a JEM 1200 electron microscope. HRP contain-
ing endosomes were photographed randomly for further
analysis.
Frozen colon tissue was weighed and immersed into lysis
buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM
Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyro-
phosphate, 1 mM β -glycerophosphate, 1 mM Na3VO4
(sodium ortho-vanadate), 1 µg/ml leupeptin) and
homogenized on ice; the homogenates and colon content
were centrifuged at 1,500 g for 20 minutes at 4°C respec-
tively, the supernatants were collected for HRP assay. HRP
amount in colon content and colon tissue was determined
by assaying enzyme activity in the collected supernatant
according to the previous report [18]. Briefly, a 0.2-ml
sample of supernatant was mixed with 2.8 ml phosphate
buffer (0.1 M, pH 6.0) containing 0.003% H2O2 and
0.025 ml of a solution of o-dianisidine di-HCl (10 mg/
ml). The optical density was determined at 460 nm with a
spectrophotometer.
Intestinal sensitization to luminal OVA with the presence 
of SEB-containing SWF
Ten mice were used for each group. A group of mice was
sensitized by means of intragastric gavage with 50 µg OVA
in 0.2 ml alum-SWF (the adjuvant, prepared with SWF
instead of distilled water that contains 50 µg SEB).
Another group was also treated with the same protocol,
but the SWF in the adjuvant was pretreated with an anti-
SEB antibody (100 µg in 0.2 ml). Control groups were
designed as: mice were only exposed to OVA without the
presence of SWF, or were only exposed to SWF without
OVA; naïve controls were treated with 0.2 ml saline. Each
mouse was injected with 50 ng pertussis toxin
peritoneally.
Mice were challenged with specific antigen OVA
From the 14th day after sensitization, all mice were chal-
lenged with 50 mg OVA in 0.3 ml saline by means of
intragastric gavage 3 times, 48 h apart. Diarrhea was deter-
mined by visually monitoring mice for up to 1 hour fol-
lowing intragastric challenge. Mice demonstrating profuse
liquid stool were recorded as diarrhea-positive animals.
Two days after the last challenge, mice were sacrificed by
decapitation; blood samples were collected, serum was
separated and stored at -70°C for further analysis. Colon
was removed, one piece was fixed with 4% paraformalde-
hyde for histology; one piece was snap frozen for MPO
analysis; one piece was fixed with Carnoy solution for
mast cell count; one piece was fixed with 2% glutaralde-
hyde for electron microscopy.
Myeloperoxidase activity evaluation
Myeloperoxidase (MPO) activity was determined accord-
ing to the method of Bradley et al [19]. Tissue samples
were homogenized in hexadecyltrimethylammonium
bromide buffer in a glass homogenizer on ice. The
homogenates were centrifuged and MPO activity in the
supernatants was determined. One unit of MPO activity
was defined as the amount required to degrade 1 mM
H2O2 in 1 minute at 25°C.BMC Gastroenterology 2005, 5:6 http://www.biomedcentral.com/1471-230X/5/6
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Colonic mucosal inflammatory score
The morphology of the epithelium, villi, and subepithe-
lial layer of colon mucosa were assessed, and the numbers
of eosinophils and mononuclear cells were counted in 10
randomly selected fields (magnification, ×400) for each
mouse (100/group). To determine mast cell numbers, tis-
sues were fixed in Carnoy's fixative and paraffin sections
were stained with 0.5% toluidine blue. Mast cells were
counted in 10 fields for each mouse (100/group). Cell
numbers were expressed per mm2 of mucosa. All sections
were coded to avoid observer bias. The degree of inflam-
mation on microscopic tissue sections was scored as fol-
lows: (from 0 to 4, 0 indicates normal, 4 indicates severe
condition): 0, no leukocyte infiltration; 1, low level of leu-
kocyte infiltration; 2, moderate level of leukocyte infiltra-
tion; 3, high vascular density and thickening of the colon
wall; and 4, transmural leukocyte infiltration, loss of gob-
let cells, high vascular density, and thickening of the colon
wall. Grading was done in a blinded manner [20].
Observation of mast cell and eosinophil activation
Colon tissue was processed with routine procedures and
observed with an electron microscope. Activation of mast
cell and eosinophil in colonic mucosa was determined by
the phenomenon of degranulation [21].
Serum specific IgE measurement
Passive cutaneous anaphylaxis (PCA) was employed to
determine serum OVA-specific IgE level. The serum was
diluted in phosphate-buffered saline (PBS) from 1:4 to
1:128. The mice were injected intradermally with 50 µl
serum into each of 4 dorsal shaved skin sites. The sites
were outlined with a water-insoluble red marker. Forty-
eight hours later each mouse received an injection of 0.1
ml OVA (1 mg/ml) containing 4% Evans blue via the tail
vein. The results were recorded thirty minutes after the
challenge; the diameter of the blue spot on the injection
sites larger than 6 mm was recorded as positive reaction.
Statistics
Data were expressed as mean ± SD; Student t test was used
to compare the difference between groups. p < 0.05 was
accepted as significant criteria.
Results
Staphylococcus enterotoxin B was detected in SWF from 
the patients with both CS and UC
The content of SEB was significantly higher in the SWF of
patients with both UC and CS (from 30.5 to 565.6, with
an average of 154.5 ± 81.7 pg/ml) than in the nasal wash
fluids (from 0 to 18.6, with an average of 8.5 ± 4.3 pg/ml)
of healthy control subjects.
Stimulation with SWF increased mouse colonic mucosal 
permeability to luminal macromolecular protein HRP
Horseradish peroxisase activity was detected in colonic
content in both control mice (group of HRP-only and
group of anti-SEB treated SWF) and SWF treated mice (Fig
1A). The HRP activity was significantly higher in the
colonic tissue of the mice treated with SWF compared to
controls (Fig 1B). Observation with EM revealed that few
HRP endosomes of small size were observed in the upper
region (above the nucleus) of cytoplasm in the colonic
epithelium of control mice. Large size HRP endosomes
were observed in both upper and lower (below the upper
edge of the nucleus) regions of the mice treated SWF.
Image analysis of HRP endosome showed that the HRP
endosome area was significantly larger in the mice treated
with SWF comparing with those control mice (Fig 2).
Serum specific anti-OVA IgE was detected in the mice 
treated with SWF and luminal OVA
Passive cutaneous anaphylaxis (PCA) is the gold standard
method to measure allergen-specific IgE antibody levels in
mouse models of allergy. The present study demonstrated
that only the group treated with both SWF and OVA
showed positive results with the highest titer 1:64. No spe-
cific IgE was detected in the serum of mice in control
groups.
Activation of mast cells and eosinophils in the colonic 
mucosa of the sensitized mice after challenging with 
specific antigen
Activation of mast cells and eosinophils was observed as
degranulation of the granules in the cytoplasm. Piecemeal
type degranulation was observed more often than the ana-
phylactic type in the mast cells in the colonic mucosa of
the sensitized mice with EM. Crystal core degranulation
and matrix degranulation were observed in eosinophils of
the sensitized mice. Granules were categorized intact or
degranulated for each mast cell or eosinophil. Each type
granule was numerated with EM. After challenge with spe-
cific antigen OVA, degranulation was observed in both
mast cells and eosinophils of the sensitized mice. The
ratio of degranulation was much higher in the sensitized
mice compared with controls (Fig 3).
Histopathology of colonic mucosa of the sensitized mice 
after challenge with specific antigen
Challenge with specific antigen OVA resulted in inflam-
matory cell infiltration in the lamina propria and subepi-
thelial regions. The infiltrate consisted of mainly mast
cells, eosinophils and mononuclear cells. Compared with
control, the sensitized group showed significantly more
inflammatory cell infiltration, most of them might be acti-
vated immune cells (Fig 4). Capillary or small vein dila-
tion was observed in the subepithelial region of the
intestinal mucosa after OVA challenge; profound edemaBMC Gastroenterology 2005, 5:6 http://www.biomedcentral.com/1471-230X/5/6
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Mouse colonic epithelial permeability increased by stimula- tion of SWF Figure 1
Mouse colonic epithelial permeability increased by 
stimulation of SWF. Bars stand for HRP activity in colonic 
content (Fig 1A) and colonic tissue (Fig 1B). Each group con-
sists of 10 mice. *, p < 0.05, compared with controls.
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HRP endosomes in the colonic mucosa. Representative 
EM photomicrographs were taken from colonic mucosa of 
control (Fig 2A) and sensitized mice (Fig 2B). Bars stand for 
HRP endosome area in 300 µm2 cell area (Fig 2C). *, p < 
0.05, compared with controls.
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Activation of mast cell and eosinophil in the colonic mucosa Figure 3
Activation of mast cell and eosinophil in the colonic mucosa. Representative photomicrographs (10 for each mouse) 
were taken from colonic mucosa of naïve mice (Fig 3A, 3C) and sensitized mice (Fig 3B, 3D). Bars stand for ratio of degranula-
tion that was calculated with the numbers of degranulated granules divided by the numbers of total granules of mast cells (Fig 
3E) and eosinophils (Fig 3F). *, p < 0.05, compared with naïve controls.
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in the tissue of the same area was frequently observed (Fig
6B, 6F).
Inflammatory status in the colonic mucosa was assessed
by colonic tissue MPO measurement, inflammatory cell
infiltration and mucosal surface condition observation.
Inflammatory cell infiltration in the colonic mucosa Figure 4
Inflammatory cell infiltration in the colonic mucosa. 
Bars stand for numbers of mast cell (Fig 4A), eosinophil (Fig 
4B) and mononuclear cell (Fig 4C). Cell numbers are 
expressed as cells/mm2 tissue. *, p < 0.05, compared with 
naïve controls.
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MPO activity and inflammatory scores of the colonic mucosa Figure 5
MPO activity and inflammatory scores of the colonic 
mucosa. Colonic tissues show an increased MPO activity 
(A) and increased inflammatory scores (B) after challenge 
with OVA. *, p < 0.05, compared with naïve controls.
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Ultrapathology of the colonic mucosa of the sensitized mice after challenge with OVA Figure 6
Ultrapathology of the colonic mucosa of the sensitized mice after challenge with OVA. Representative EM phot-
omicrographs are taken from the colonic mucosa of the sensitized mice after challenge with OVA and show (A) epithelial cell 
(epi) necrosis (EN) and dilation of the blood vessel (BV) in the subepithelial region (×3,000); (B) epithelium destruction, base-
ment membrane (BM) hyperplasia and blood vessel dilation (×2,000); (C) bacteria (arrows) adhering to and penetrating the epi-
thelial cells (×3,000); (D) abscess (Ab) formation in subepithelial region with a colony of bacteria (arrows) and a red blood cell 
(RBC) in it (×2,000); (E) micro-ulcer (empty arrow) formation on the surface of colonic mucosa with bacteria (arrow) adher-
ence (×2,500); (F) edema and blood vessel (BV) dilation in the lamina propria (LP) (×2,500).
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MPO is a critical parameter that indicates activation of
neutrophils. We observed a significant increase in MPO
and inflammatory score in colonic mucosa after challenge
with OVA in the mice treated with SWF and OVA (Fig 5).
Electron microscopy revealed ultrapathology in the sensi-
tized and OVA-challenged colonic mucosa that included:
(i) epithelial cell destruction (Fig 6A, B); (ii) bacteria
adherent to or penetrating the epithelial cells; (iii) bacte-
ria translocated to the subepithelial region and abscess
formation (Fig 6C, D); (iv) micro-ulcer formation on the
surface of the colonic mucosa (Fig 6E); (v) edema in lam-
ina propria (Fig 6F).
Challenge with specific antigen OVA induced diarrhea in 
the sensitized mice
Following the protocol of challenge with specific antigen
OVA, the sensitized mice developed diarrhea 15–30 min-
utes after each challenge that lasted up to 1 hour. The
number of diarrhea episodes (3 to 7 times) increased in
parallel with the number of OVA challenges. No diarrhea
was noted in control mice although those mice also
received the same number of OVA challenges. Diarrhea
was also noted by direct observation of the colon and
cecum; the liquid stool observed following OVA chal-
lenge-induced diarrhea in the sensitized mice contrasts
with the solid pellets seen in the distal colon of other mice
in control groups.
Discussion
Our knowledge about the etiology of ulcerative colitis is
still limited. Although some theories about its origins
have been advanced, such as genetic predisposition,
autoimmune disorders, infection, and so on [23,24], the
precise pathogenesis needs to be further understood. In
clinical practice, we noted a close association between CS
and UC in some patients and their UC was significantly
improved after having removed sinus pathology (data not
shown). The results of animal experiments verified our
speculation: superantigen SEB from sinusitis cooperated
with ingested antigen to induce intestinal sensitization.
Challenge with the obligate antigen initiated colonic
mucosal inflammation as well as the clinical symptom
diarrhea. Book DT et al [25] also noted the same phenom-
enon and suggested that IBD was more prevalent in those
people with chronic sinusitis than in other populations.
Rhinosinuses are empty cavities lined with mucosa. The
anatomic feature, only having a small ostium, makes
them very easily to be blocked and subsequently infected.
Infection with S. aureus in sinuses is frequently encoun-
tered [4,5]. Thus, chronically infected sinuses may be a
source of SEB that is released to nasal cavity frequently. A
mucus blanket on the surface of nasal mucosa naturally
traps small particles from air and the secretions from
sinuses and removes them subsequently. Since the direc-
tion of the locomotion of the mucus blanket is backward,
people sometimes swallow the secretions into the gas-
trointestinal tract (e.g., during sleep).
There are many toxic substances in the secretions from
chronic sinusitis. SEB is one that has been well character-
ized. The unique feature of SEB is that it can down regu-
late intestinal barrier function [6,13], activate T
lymphocytes without the help from antigen presenting
cells to activate T cells. Superantigens bind directly to
MHC class II molecules and to a subset of T-cell receptor
(TCR) Vβ  chains [26,27]. Unlike conventional antigens,
superantigens do not require processing by antigen-pre-
senting cells to activate immune cells [31]. Administration
of superantigen results in initial selective expansion of T
cells that bear specific Vβ  chains that recognize the super-
antigen, followed by their deletion [29]. Another unique
feature of superantigen is that it mutes T suppression cell
function and promotes Th1/Th2 skewing [30]. It primes
an environment to develop sensitization in local tissue.
The results in the present animal experiments are consist-
ent with previous studies. Mice treated with SEB-contain-
ing SWF and OVA developed intestinal sensitization, but
not in those mice treated with only OVA, or SEB-depleted
SWF plus OVA. This finding demonstrates that SEB plays
a crucial role in the sensitization of the intestinal mucosa
to luminal antigen in these mice. Louini D et al [31]
reported that SEB also directly sensitized skin and caused
Th2 pattern inflammation in the local skin.
Intestinal epithelial cells form a barrier between the lumi-
nal contents and the subepithelial region. The barrier
restricts substances to be absorbed. It only allows some
small molecules such as water to pass it freely. Antigens
are macromolecular proteins that are not allowed to be
absorbed before being digested to small peptides or
amino acids under normal physiological conditions. But
in reality, intact antigens do pass the intestinal barrier to
reach lamina propria to induce inappropriate immune
reactions under certain circumstance. How antigens cross
the intestinal epithelial barrier is still a mystery. By intro-
ducing both SWF and HRP to mouse gastrointestinal tract,
intact HRP in the colonic tissue was increased nearly 11
times compared to control. The results implicate that
superantigen SEB is one of the factors that facilitate anti-
gens to be absorbed without destroying their antigenicity.
Lu et al also reported that SEB significantly increased
colonic mucosal permeability in a mouse study [13].
We have begun to appreciate that food allergy plays a role
in the inflammation of intestinal mucosa [32]. The results
of this animal model support that inappropriate immune
reactions initiate intestinal inflammation. Simply
delivering OVA to gastrointestinal tract did not show sen-BMC Gastroenterology 2005, 5:6 http://www.biomedcentral.com/1471-230X/5/6
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sitization in the mice while the combination of SEB-con-
taining SWF and OVA induced sensitization in the colonic
mucosa. Based on these data, we suggest that SEB facilitate
sensitization of the intestinal mucosa to OVA. The mech-
anism behind this phenomenon might be that SEB
increases permeability of the intestinal mucosa [6,13].
Thus OVA in the intestinal lumen can be transported to
deep region of the mucosa. This exogenous protein then
contacts the local immune cells to initiate inappropriate
immune reactions and sensitizes the mucosa subse-
quently. The results of challenge with OVA show extensive
inflammation in the colonic mucosa in this study. The
inflammatory changes may be a result of local mast cell
degranulation in response to OVA challenge. Mast cells
release chemical mediators such as histamine that is able
to increase vascular permeability and to induce edema in
the tissue that was noted in the present study and also
reported elsewhere [33].
In chronic allergic diseases such as asthma, during contin-
uous antigen exposure, eosinophils are primed by IL-5
and attracted by chemokines, infiltrating the local tissue
[34]. We also observed extensive eosinophil infiltration in
the colonic tissue after three challenges with specific anti-
gen OVA in the present study. These eosinophils are
believed to be responsible for the late phase of the allergic
reaction, producing the major basic protein which is toxic
to the epithelium [34]. The micro-ulcers on the surface of
colonic mucosa may be caused by eosinophil activation.
Supportive evidence acquired from EM observation dem-
onstrates that most eosinophils have been activated by
showing extensive degranulation. We also noted this phe-
nomenon in the jejunal mucosa in the late phase reaction
in a rat model of food allergy [32].
Marked mast cell hyperplasia in the colonic tissue was
observed in this study. In general, mast cell numbers in
tissues are relatively constant, even though mast cell
hyperplasia is observed in both the inflammatory and in
repair/remodeling stage of various inflammatory disor-
ders [35]. The functional significance of the accumulation
of mast cells in these processes is largely unknown. In
allergy, apart from their classical role in eliciting the early
phase, mast cells also have an important role in late and
chronic stages as we observed in a previous study [32]. In
these stages they may interact with and be activated by
infiltrated inflammatory cells and by resident structural
cells such as epithelial cells, smooth muscle cells and
fibroblasts. In the case of allergic reaction, mast cells are
mainly activated by the mechanism of IgE mediated Fcε RI
bridging that accounts for the mast cell activation in the
present study. The roles of mast cells in the late phase reac-
tions may be amplified by eosinophils, platelets and neu-
trophils [36]. If a sensitized patient frequently ingests an
obligate antigen unconsciously whereas the allergic reac-
tion only reaches subclinical level, an early inflammation
may progress without being noticed until reaching the
advanced stage. The data also show that the degranulation
type of mast cells and eosinophils in this study is mainly
piecemeal. It indicates that the nature of the
degranulation type belongs to a chronic process [37]. The
local inflammation may progress to chronic status in the
tissue without any further medical intervention.
Striking epithelial damage of colonic mucosa of the sensi-
tized mice after challenge with OVA was observed in this
study. This phenomenon has been well-documented in
airway allergy [38]. Although ulcers are one of the main
clinical signs in inflammatory bowel diseases, the etiology
is not clear. There have not been many studies considering
an association between the ulcers and allergic reactions in
the gastrointestinal tract. Eosinophil released major basic
protein is suggested to be the major offender to cause epi-
thelial cell exfoliation in the airway mucosa [38]. The
erosion and prominent damage to the epithelial barrier
can explain the phenomenon of bacterial adhering to and
penetrating to colonic mucosa in this study. These
bacteria are commensal bacteria. They usually are not con-
sidered pathogenic. The damaged epithelium may pro-
vide an entry port for the colonizing bacteria to invade the
colonic mucosa and to establish an infection.
Conclusion
In summary, we reported a murine model of ulcerative
colitis in this paper that was induced with sinusitis-
derived SEB and OVA sensitization followed by repeat
challenges with specific antigen OVA. The histopathology
of the colonic mucosa included inflammatory cell infiltra-
tion, activation of mast cell/eosinophil, epithelial barrier
damage, micro-ulcer formation on the surface of colonic
mucosa, bacteria translocation and abscesses formation in
the subepithelial region.
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